NPM1
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
NPM1; nucleophosmin (nucleolar phosphoprotein B23, numatrin); B23; NPM; nucleophosmin; nucleolar protein NO38; nucleophosmin/nucleoplasmin family, member 1;
NPM3
nucleophosmin/nucleoplasmin 3
NPM3; nucleophosmin/nucleoplasmin 3; nucleoplasmin-3; NPM 3; RGD1565542; Nub1; nucleophosmin/nucleoplasmin family, member 3; nucleophosmin/nucleoplasmin, 3; Nucleoplasmin 3; PORMIN; TMEM123; OTTHUMP00000020352;
CCM2
cerebral cavernous malformation 2
CCM2; cerebral cavernous malformation 2; C7orf22, chromosome 7 open reading frame 22; malcavernin; MGC4607; C7orf22; CCM2_HUMAN; Cerebral cavernous malformations 2 protein; MGC4067; MGC74868; OTTHUMP00000159554; OTTHUMP00000214270; OTTHUMP00000214271; OTTHUMP00000214273; PP10187; OSM;
GlaxoSmithKline’s Scientific Study Data was Questioned
There are always rumors and scandals. This time the scandal spread to scientific community and made GlaxoSmithKline (GSK) becoming the major topic of this week as a panel discusses the potential risks of the questioned drug. GSK, the London-based drug giant recently has co...
Immunocore Cooperates with GlaxoSmithKline to Target on Cancer and Viral Disease
On July 9, 2013, Immunocore announced that it has entered into a partnership with GlaxoSmithKlinefor multiple novel targets after signing the research and licensing agreement to discover and develop novel biological drugsImmune mobilising mTCR Against Cancer (ImmTACs) in earlier times. ...
